Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Figure 5

Kaplan-Meyer plot of cumulative proportion of patients remaining free from new gadolinium enhancing (Gd⁺) lesions at magnetic resonance imaging over time from start of fingolimod therapy.